Navigation Links
Changes in narcoleptics' skin, core body temperatures affect their vigilance and sleepiness
Date:2/1/2008

WESTCHESTER, Ill. In healthy people, both sleepiness and vigilance show a relationship with core body temperature and skin temperature. When core body temperature is high during the daytime, skin temperature is low, which translates into optimal vigilance. Conversely, when core body temperature is low at night time, skin temperature is high, which correlates to optimal sleep. Among those suffering from narcolepsy, however, direct manipulations of their skin and core body temperatures affect their vigilance and sleepiness, according to a study published in the February 1 issue of the journal SLEEP.

The study, authored by Rolf Fronczek, of the Netherlands Institute for Neuroscience in Amsterdam, and Leiden University Medical Center in The Netherlands, focused on eight patients who were diagnosed with narcolepsy with cataplexy and suffered from excessive daytime sleepiness. The subjects vigilance was measured using the Psychomotor Vigilance Task, and their sleepiness was assessed with the Maintenance of Wakefulness Test. Meanwhile, their skin temperature was mildly manipulated using a thermosuit, while their core body temperature was manipulated using hot or cold food and drinks.

According to the results, patients were better able to maintain vigilance when core body temperature was increased than when it was lowered, indicating that vigilance in narcolepsy can be altered simply by altering the temperature of food and drinks. Also, the ability to maintain wakefulness was better when skin temperature was lowered than when it was increased. Therefore, the process of falling asleep in narcoleptic subjects was able to be influenced by gently cooling or warming their hands and feet.

Patients with narcolepsy lack a specific neurotransmitter in their brains. This neurotransmitter is responsible for the regulation of the sleep/wake rhythm. That is why narcoleptic patients fall asleep during the day, but have problems sleeping during th
'/>"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. QED International Associates Announces Changes to the HealthShares(TM) European Medical Products and Devices Index
2. Changes needed in how federal government evaluates efficiency of research at EPA, other agencies
3. DuPont Announces Leadership Changes
4. EpicTide Changes Name to FairWarning(R)
5. XLHealth Corporation Announces Executive Changes
6. OPKO Health Announces Changes to Board of Directors
7. Small Lifestyle Changes Can Boost Longevity
8. QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index
9. URAC Calls for Comments on Changes to Standards for Health Web Site, HIPAA Privacy and Security Accreditation Programs
10. Significant changes in plastic surgery expected in 2008
11. Standard & Poors Announces Changes to U.S. Indices
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2Health News:Help Young Cancer Patients Enjoy Christmas This Season 2
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5The Worlds Only Online Marketplace Dedicated to Buying and Selling Gently Used and New Special Needs Equipment 3A DifferentNeedz com 5284 1The Worlds Only Online Marketplace Dedicated to Buying and Selling Gently Used and New Special Needs Equipment 3A DifferentNeedz com 5284 2Marc J Fagel of the U S Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech Pharma Finance and Accounting Forum in San Fra 5282 1Marc J Fagel of the U S Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech Pharma Finance and Accounting Forum in San Fra 5282 2Mike Fuljenz and Universal Coin 26amp 3B Bullion Sponsors the NRA Eddie Eagle GunSafe Program 14381 1Mike Fuljenz and Universal Coin 26amp 3B Bullion Sponsors the NRA Eddie Eagle GunSafe Program 14381 2